Schedule 13G ownership disclosure
Juno Therapeutics, Inc.
Security class unavailable · CUSIP: 48205A109
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,547,788
- Percent of class
- 9.2400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001088875-18-000006
- Form type
- SC 13G
- Filer
- BAILLIE GIFFORD & CO
- CIK
- CIK 1088875
- Filed
- Jan 10, 2018
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership